{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:12:43Z","timestamp":1775002363135,"version":"3.50.1"},"publisher-location":"Cham","reference-count":40,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032041524","type":"print"},{"value":"9783032041531","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-04153-1_24","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:16:26Z","timestamp":1774998986000},"page":"405-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influenza Virus Neuraminidase Glycoprotein, Its Inhibitors, and Their Resistance"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9064-4699","authenticated-orcid":false,"given":"Emi","family":"Takashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002431","volume":"7","author":"Y Abed","year":"2011","unstructured":"Abed Y, Pizzorno A, Bouhy X, Boivin G (2011) Role of permissive neuraminidase mutations in influenza A\/Brisbane\/59\/2007-like (H1N1) viruses. PLoS Pathog 7:e1002431. https:\/\/doi.org\/10.1371\/journal.ppat.1002431","journal-title":"PLoS Pathog"},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0042-6822(91)90003-t","volume":"180","author":"LG Baum","year":"1991","unstructured":"Baum LG, Paulson JC (1991) The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity. Virology 180:10\u201315. https:\/\/doi.org\/10.1016\/0042-6822(91)90003-t","journal-title":"Virology"},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1086\/650464","volume":"201","author":"M Baz","year":"2010","unstructured":"Baz M, Abed Y, Simon P, Hamelin ME, Boivin G (2010) Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis 201:740\u2013745. https:\/\/doi.org\/10.1086\/650464","journal-title":"J Infect Dis"},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1126\/science.1187816","volume":"328","author":"JD Bloom","year":"2010","unstructured":"Bloom JD, Gong LI, Baltimore D (2010) Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328:1272\u20131275. https:\/\/doi.org\/10.1126\/science.1187816","journal-title":"Science"},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1128\/JVI.07242-12","volume":"86","author":"NM Bouvier","year":"2012","unstructured":"Bouvier NM, Rahmat S, Pica N (2012) Enhanced mammalian transmissibility of seasonal influenza A\/H1N1 viruses encoding an oseltamivir-resistant neuraminidase. J Virol 86:7268\u20137279. https:\/\/doi.org\/10.1128\/JVI.07242-12","journal-title":"J Virol"},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/j.1460-2075.1992.tb05026.x","volume":"11","author":"WP Burmeister","year":"1992","unstructured":"Burmeister WP, Ruigrok RW, Cusack S (1992) The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J 11:49\u201356. https:\/\/doi.org\/10.1002\/j.1460-2075.1992.tb05026.x","journal-title":"EMBO J"},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1128\/JVI.67.6.2972-2980.1993","volume":"67","author":"PM Colman","year":"1993","unstructured":"Colman PM, Hoyne PA, Lawrence MC (1993) Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol 67:2972\u20132980. https:\/\/doi.org\/10.1128\/JVI.67.6.2972-2980.1993","journal-title":"J Virol"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1128\/JVI.06085-11","volume":"86","author":"TE Ginting","year":"2012","unstructured":"Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y (2012) Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J Virol 86:121\u2013127. https:\/\/doi.org\/10.1128\/JVI.06085-11","journal-title":"J Virol"},{"key":"24_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105281","volume":"200","author":"EA Govorkova","year":"2022","unstructured":"Govorkova EA, Takashita E, Daniels RS, Fujisaki S, Presser LD, Patel MC, Huang W, Lackenby A, Nguyen HT, Pereyaslov D, Rattigan A, Brown SK, Samaan M, Subbarao K, Wong S, Wang D, Webby RJ, Yen HL, Zhang W, Meijer A, Gubareva LV (2022) Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020. Antivir Res 200:105281. https:\/\/doi.org\/10.1016\/j.antiviral.2022.105281","journal-title":"Antivir Res"},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2017.08.004","volume":"146","author":"LV Gubareva","year":"2017","unstructured":"Gubareva LV, Besselaar TG, Daniels RS, Fry A, Gregory V, Huang W, Hurt AC, Jorquera PA, Lackenby A, Leang SK, Lo J, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Odagiri T, Wang D, Zhang W, Meijer A (2017) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015\u20132016. Antivir Res 146:12\u201320. https:\/\/doi.org\/10.1016\/j.antiviral.2017.08.004","journal-title":"Antivir Res"},{"key":"24_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.antiviral.2016.06.001","volume":"132","author":"AC Hurt","year":"2016","unstructured":"Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W, Meijer A (2016) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014\u20132015. Antivir Res 132:178\u2013185. https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.001","journal-title":"Antivir Res"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1128\/JVI.72.9.7367-7373.1998","volume":"72","author":"T Ito","year":"1998","unstructured":"Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367\u20137373. https:\/\/doi.org\/10.1128\/JVI.72.9.7367-7373.1998","journal-title":"J Virol"},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jinf.2009.07.002","volume":"59","author":"N Kawai","year":"2009","unstructured":"Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Kashiwagi S (2009) Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation. J Infect 59:207\u2013212. https:\/\/doi.org\/10.1016\/j.jinf.2009.07.002","journal-title":"J Infect"},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/nm.2954","volume":"18","author":"A Kelso","year":"2012","unstructured":"Kelso A, Hurt AC (2012) The ongoing battle against influenza: drug-resistant influenza viruses: why fitness matters. Nat Med 18:1470\u20131471. https:\/\/doi.org\/10.1038\/nm.2954","journal-title":"Nat Med"},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1128\/JVI.73.8.6743-6751.1999","volume":"73","author":"D Kobasa","year":"1999","unstructured":"Kobasa D, Kodihalli S, Luo M, Castrucci MR, Donatelli I, Suzuki Y, Suzuki T, Kawaoka Y (1999) Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J Virol 73:6743\u20136751. https:\/\/doi.org\/10.1128\/JVI.73.8.6743-6751.1999","journal-title":"J Virol"},{"key":"24_CR16","doi-asserted-by":"publisher","unstructured":"Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC (2008) Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 13. https:\/\/doi.org\/10.2807\/ese.13.05.08026-en","DOI":"10.2807\/ese.13.05.08026-en"},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.antiviral.2018.07.001","volume":"157","author":"A Lackenby","year":"2018","unstructured":"Lackenby A, Besselaar TG, Daniels RS, Fry A, Gregory V, Gubareva LV, Huang W, Hurt AC, Leang SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiri T, Pereyaslov D, Takashita E, Wang D, Zhang W, Meijer A (2018) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016\u20132017. Antivir Res 157:38\u201346. https:\/\/doi.org\/10.1016\/j.antiviral.2018.07.001","journal-title":"Antivir Res"},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1743-422X-7-53","volume":"7","author":"Y Matsuzaki","year":"2010","unstructured":"Matsuzaki Y, Mizuta K, Aoki Y, Suto A, Abiko C, Sanjoh K, Sugawara K, Takashita E, Itagaki T, Katsushima Y, Ujike M, Obuchi M, Odagiri T, Tashiro M (2010) A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virol J 7:53. https:\/\/doi.org\/10.1186\/1743-422X-7-53","journal-title":"Virol J"},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","volume":"10","author":"JL McAuley","year":"2019","unstructured":"McAuley JL, Gilbertson BP, Trifkovic S, Brown LE, McKimm-Breschkin JL (2019) Influenza virus neuraminidase structure and functions. Front Microbiol 10:39. https:\/\/doi.org\/10.3389\/fmicb.2019.00039","journal-title":"Front Microbiol"},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2014.07.001","volume":"110","author":"A Meijer","year":"2014","unstructured":"Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS, Hurt AC (2014) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012\u20132013. Antivir Res 110:31\u201341. https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.001","journal-title":"Antivir Res"},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3851\/IMP1804","volume":"16","author":"MA Rameix-Welti","year":"2011","unstructured":"Rameix-Welti MA, Munier S, Le Gal S, Cuvelier F, Agou F, Enouf V, Naffakh N, van der Werf S (2011) Neuraminidase of 2007\u20132008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution. Antivir Ther 16:597\u2013603. https:\/\/doi.org\/10.3851\/IMP1804","journal-title":"Antivir Ther"},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0042-6822(83)90150-2","volume":"127","author":"GN Rogers","year":"1983","unstructured":"Rogers GN, Paulson JC (1983) Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127:361\u2013373. https:\/\/doi.org\/10.1016\/0042-6822(83)90150-2","journal-title":"Virology"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature05114","volume":"443","author":"RJ Russell","year":"2006","unstructured":"Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443:45\u201349. https:\/\/doi.org\/10.1038\/nature05114","journal-title":"Nature"},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/INF.0b013e3181de9d24","volume":"29","author":"R Saito","year":"2010","unstructured":"Saito R, Sato I, Suzuki Y, Baranovich T, Matsuda R, Ishitani N, Dapat C, Dapat IC, Zaraket H, Oguma T, Suzuki H (2010) Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation. Pediatr Infect Dis J 29:898\u2013904. https:\/\/doi.org\/10.1097\/INF.0b013e3181de9d24","journal-title":"Pediatr Infect Dis J"},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/440435a","volume":"440","author":"K Shinya","year":"2006","unstructured":"Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y (2006) Avian flu: influenza virus receptors in the human airway. Nature 440:435\u2013436. https:\/\/doi.org\/10.1038\/440435a","journal-title":"Nature"},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08182","volume":"459","author":"GJ Smith","year":"2009","unstructured":"Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122\u20131125. https:\/\/doi.org\/10.1038\/nature08182","journal-title":"Nature"},{"key":"24_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005411","volume":"12","author":"H Song","year":"2016","unstructured":"Song H, Qi J, Khedri Z, Diaz S, Yu H, Chen X, Varki A, Shi Y, Gao GF (2016) An open receptor-binding cavity of hemagglutinin-esterase-fusion glycoprotein from newly-identified influenza D virus: basis for its broad cell tropism. PLoS Pathog 12:e1005411. https:\/\/doi.org\/10.1371\/journal.ppat.1005411","journal-title":"PLoS Pathog"},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/pathogens10121583","volume":"10","author":"CC Sreenivasan","year":"2021","unstructured":"Sreenivasan CC, Sheng Z, Wang D, Li F (2021) Host range, biology, and species specificity of seven-segmented influenza viruses\u2014a comparative review on influenza C and D. Pathogens 10:1583. https:\/\/www.mdpi.com\/2076-0817\/10\/12\/1583","journal-title":"Pathogens"},{"key":"24_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038687","volume":"11","author":"E Takashita","year":"2021","unstructured":"Takashita E (2021) Influenza polymerase inhibitors: mechanisms of action and resistance. Cold Spring Harb Perspect Med 11:a038687. https:\/\/doi.org\/10.1101\/cshperspect.a038687","journal-title":"Cold Spring Harb Perspect Med"},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-0716-2635-1_19","volume":"2556","author":"E Takashita","year":"2022","unstructured":"Takashita E (2022) Assays for determining the Sialidase activity of influenza viruses and monitoring influenza virus susceptibility to neuraminidase inhibitors. Methods Mol Biol 2556:287\u2013302. https:\/\/doi.org\/10.1007\/978-1-0716-2635-1_19","journal-title":"Methods Mol Biol"},{"key":"24_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","volume":"117","author":"E Takashita","year":"2015","unstructured":"Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC, Tashiro M (2015) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013\u20132014. Antivir Res 117:27\u201338. https:\/\/doi.org\/10.1016\/j.antiviral.2015.02.003","journal-title":"Antivir Res"},{"key":"24_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104718","volume":"175","author":"E Takashita","year":"2020","unstructured":"Takashita E, Daniels RS, Fujisaki S, Gregory V, Gubareva LV, Huang W, Hurt AC, Lackenby A, Nguyen HT, Pereyaslov D, Roe M, Samaan M, Subbarao K, Tse H, Wang D, Yen HL, Zhang W, Meijer A (2020) Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017\u20132018. Antivir Res 175:104718. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104718","journal-title":"Antivir Res"},{"key":"24_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/(sici)1099-1654(200001\/02)10:1<45::aid-rmv265>3.0.co;2-r","volume":"10","author":"M Tisdale","year":"2000","unstructured":"Tisdale M (2000) Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors. Rev Med Virol 10:45\u201355. https:\/\/doi.org\/10.1002\/(sici)1099-1654(200001\/02)10:1<45::aid-rmv265>3.0.co;2-r","journal-title":"Rev Med Virol"},{"key":"24_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-1-59745-180-2_31","volume-title":"Antimicrobial drug resistance","author":"M Tisdale","year":"2009","unstructured":"Tisdale M (2009) Influenza M2 ion-channel and neuraminidase inhibitors. In: Mayers DL (ed) Antimicrobial drug resistance. Humana Press, pp 421\u2013447. https:\/\/doi.org\/10.1007\/978-1-59745-180-2_31"},{"key":"24_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0022-2836(91)80068-6","volume":"221","author":"JN Varghese","year":"1991","unstructured":"Varghese JN, Colman PM (1991) Three-dimensional structure of the neuraminidase of influenza virus A\/Tokyo\/3\/67 at 2.2 A resolution. J Mol Biol 221:473\u2013486. https:\/\/doi.org\/10.1016\/0022-2836(91)80068-6","journal-title":"J Mol Biol"},{"key":"24_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/303035a0","volume":"303","author":"JN Varghese","year":"1983","unstructured":"Varghese JN, Laver WG, Colman PM (1983) Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 303:35\u201340. https:\/\/doi.org\/10.1038\/303035a0","journal-title":"Nature"},{"key":"24_CR37","first-page":"369","volume":"87","author":"World Health Organization","year":"2012","unstructured":"World Health Organization (2012) Meetings of the WHO working group on surveillance of influenza antiviral susceptibility \u2013 Geneva, November 2011 and June 2012. Wkly Epidemiol Rec 87:369\u2013374. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23061103","journal-title":"Wkly Epidemiol Rec"},{"key":"24_CR38","unstructured":"World Health Organization (2024) Summary of NA amino acid substitutions associated with reduced inhibition by NAIs. https:\/\/www.who.int\/teams\/global-influenza-programme\/laboratory-network\/quality-assurance\/antiviral-susceptibility-influenza\/neuraminidase-inhibitor. Accessed 24 Sept 2025"},{"key":"24_CR39","unstructured":"World Health Organization (2024) Laboratory methodologies for testing the antiviral susceptibility of influenza viruses. https:\/\/www.who.int\/teams\/global-influenza-programme\/laboratory-network\/quality-assurance\/antiviral-susceptibility-influenza. Accessed 24 Sept 2025"},{"key":"24_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","volume":"22","author":"Y Wu","year":"2014","unstructured":"Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF (2014) Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 22:183\u2013191. https:\/\/doi.org\/10.1016\/j.tim.2014.01.010","journal-title":"Trends Microbiol"}],"container-title":["Advances in Experimental Medicine and Biology","The Molecular Immunology of Complex Carbohydrates - 4"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-04153-1_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:16:28Z","timestamp":1774998988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-04153-1_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032041524","9783032041531"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-04153-1_24","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}